News

AutoZone (AZO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the

Eaton (ETN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near

Symbotic Inc. (SYM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in

Power supplier The Southern Company SO reported fourth-quarter 2025 earnings per share (excluding certain one-time items) of 55 cents, missing the Zacks Consensus Estimate by a penny. The

Millicom International Cellular S.A. TIGO is set to report fourth-quarter 2025 results on Feb. 26. The Zacks Consensus Estimate for revenues is pinned at $1.56 billion, up 9% from the prior-year

Newmont Corporation NEM and Agnico Eagle Mines Limited AEM are two prominent players in the gold mining space with global operations and diversified portfolios. While gold prices have fallen from

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the

Apellis Pharmaceuticals APLS reported fourth-quarter 2025 loss of 47 cents per share, wider than the Zacks Consensus Estimate of a loss of 39 cents. The company had incurred a loss of 29 cents in

The Internet Software and Services space is gathering momentum owing to robust IT spending on solutions that support hybrid operating environments. Outstanding penetration of mobile devices among

Efficiency level measures a company’s capability to transform available input into output, and is often considered an essential parameter for gauging its potential to generate profits. A company

Investors generally tend to cling to the price-to-earnings (P/E) metric while looking for bargain stocks. In addition to being a widely used tool for screening stocks, P/E is also a popular metric

Johnson & Johnson JNJ is one of the key pharmaceutical players in the oncology segment with significant expertise in blood cancers and solid tumors. It is the #1 company in multiple myeloma, with

Super Micro Computer’s SMCI Data Center Building Block Solutions (DCBBS) is expected to grow rapidly with the AI wave and IT infrastructure demand, as the technology is experiencing wider adoption

Realty Income Corporation O reported fourth-quarter 2025 adjusted funds from operations (AFFO) per share of $1.08, which met the Zacks Consensus Estimate. The reported figure compared favorably with

Legacy automakers once relied heavily on vehicle sales, which are often cyclic in nature. Now, connected vehicles, over-the-air updates and subscription features are opening the door to

SkyWest SKYW is bolstered by its robust demand and a strong operational scenario. The company’s expansion initiative is encouraging.  Due to these tailwinds, SKYW shares have performed impressively

Growth at a reasonable price, or GARP, is an excellent strategy to earn quick investment profits. The GARP approach helps identify stocks priced below the market or any suitable target determined by

Eli Lilly’s LLY key top-line drivers are its GLP-1 medicines, Mounjaro for type II diabetes and Zepbound for obesity. Despite being on the market for slightly more than three years, Mounjaro and

Diamondback Energy, Inc. FANG reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.74, which missed the Zacks Consensus Estimate of $1.88. Moreover, the company’s bottom line

California-based electric vehicle (EV) company Lucid Group LCID posted fourth-quarter 2025 loss per share of $3.62, wider than the Zacks Consensus Estimate of $2.49 as well as $2.20 incurred in the

United Parcel Service UPS will move forward with providing $150,000 buyout offers to certain drivers after a federal judge denied an attempt by the International Brotherhood of Teamsters to halt its